← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2013Last known activity
Mar 14, 2018
Acquired by Eli Lilly on Jun 1, 2013
Timeline
2010s
- Jun 1, 2013
ARMO BioSciences— Founded
- Jun 1, 2013
Eli Lilly— Acquired By
Drugs by trial phase (12 distinct, 8 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT03554434Lead sponsorN/A—
- NCT03382912Lead sponsorPhase 2Mar 14, 2018
- NCT03382899Lead sponsorPhase 2Feb 22, 2018
- NCT04194892CollaboratorPhase 1Jan 19, 2018
- NCT03381547Lead sponsorPhase 1Jan 12, 2018
- NCT03267732Lead sponsorPhase 1Sep 5, 2017
- NCT02923921Lead sponsorPhase 3Nov 1, 2016
- NCT02009449Study directorPhase 1Nov 1, 2013
- NCT02009449Lead sponsorPhase 1Nov 1, 2013
Details
- Founded
- Redwood City, CA, US Jun 1, 2013
- Last known activity
- Mar 14, 2018